Spring Phcl Seminar Series - 10:00 AM
"Development of New Biomarkers and Therapeutic Strategies for Lethal Prostate Cancer"
Tanya Stoyanova, PhD
Canary Center for Cancer Early Detection
Department of Radiology
Stanford University School of Medicine
Dr. Stoyanova received her Ph.D. in Biochemistry and Molecular Genetics at the University of Illinois, Chicago in Dr. Pardip Raychaudhuri’s laboratory in July 2009, followed by a postdoctoral fellowship in prostate cancer biology at the University of California, Los Angeles in the laboratory of Dr. Owen Witte. In November 2015, Dr. Stoyanova joined the Department of Radiology and the Canary Center for Cancer Early Detection at Stanford University as an Assistant Professor. Stoyanova laboratory’s research focuses on understanding fundamental molecular mechanisms underlying the development of prostate and other epithelial cancers and their utility as biomarkers and therapeutic targets. The ultimate goals of Stoyanova laboratory are to improve the stratification of indolent from aggressive cancer and aid the development of better therapeutic strategies for metastatic cancer. The impact of her research has been recognized by multiple awards including the Prostate Cancer Foundation Young Investigator Award, National Institutes of Health Pathway to Independence Award, Department of Defense Idea Development Award, Stanford McCormick and Gabilan Faculty Award and most recently, the National Institutes of Health/National Cancer Institute R37 MERIT Award and others. The research in Stoyanova laboratory has led to the discovery of new mechanisms underlying the development of aggressive prostate cancer and biomarkers for significant disease as well as new therapies for prostate and other epithelial cancers.